Search

Search Constraints

You searched for: Author/Creator Domblides, Charlotte

Search Results

4. Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events. (November 2021)

5. Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA). (July 2021)

6. Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer. (September 2022)

7. Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non–Small-Cell Lung Cancer Harboring HER2 Mutations: Results From the IFCT-1703 R2D2 Trial. Issue 7 (1st March 2022)

8. Combining immune checkpoint inhibitors with chemotherapy in advanced solid tumours: A review. (November 2021)